Type 2 Diabetes and cardiovascular disease attributable to sugar beverages
New research in Nature quantifies how much type 2 diabetes and cardiovascular disease worldwide can be attributed specifically to sugar‑sweetened beverages, sharpening long‑standing concerns about liquid sugar. Commenters debate how policy should respond – from sugar taxes and marketing limits to broader regulation of processed foods – and whether such measures unfairly target personal choice or are necessary to counter powerful industry incentives. The thread also explores related issues like metabolic syndrome, the role of artificial sweeteners and GLP‑1 drugs, and the gap between nutritional evidence and what people actually drink and eat.
Health impacts of sugar-sweetened beverages (SSBs)
- Commenters largely treat the SSB–T2D/CVD link as established; this paper is seen as important mainly for quantifying global burden by country.
- Several emphasize that liquid sugar is metabolically distinct: rapid ingestion, low satiety, strong glucose/insulin spikes, promotion of visceral and liver fat.
- Some argue the metabolic-syndrome constellation (T2D, CVD, fatty liver, etc.) is driven primarily by diet and lifestyle, with SSBs near the top of the list.
Environment vs personal responsibility
- Many say blaming individuals is unfair when cheap sugar drinks are omnipresent and healthy, high‑protein or low‑sugar options are scarce or costly.
- Others push back that people can and do change via willpower and education, though this is countered with “willpower hasn’t worked at a societal level.”
- Cultural norms (e.g., soda/juice instead of water in Latin America or the US South) are seen as powerful drivers.
Regulation, universal healthcare, and industry influence
- One thread claims lack of US universal healthcare is partly because processed‑food industries fear later regulation of unhealthy products; others demand evidence and note UH countries still sell soda and tobacco.
- Sugar taxes are heavily debated:
- Evidence from places like the UK, Berkeley and several US cities suggests reduced sugary-drink purchases and reformulation toward low/zero‑sugar products.
- Critics say taxes are easily circumvented (buy in neighboring areas), regressive, and “window dressing” compared to fixing subsidies and the food system.
Diet composition: sugar, fat, carbs, seed oils
- Strong disagreement over whether saturated fat or sugar is the primary villain; some cite mainstream cardiology positions against saturated fat, others doubt studies and argue refined carbs and seed oils are worse.
- Debate over “carbohydrate poisoning”: some see excess carbs as central to modern disease; others say the issue is ultra‑processed, hyperpalatable foods, not carbs per se.
Artificial sweeteners and alternatives
- Mixed views: some see diet sodas as clearly better than sugar; others worry about microbiome effects, possible long‑term risks, and maintained “sweetness addiction.”
- People report success switching to water, tea, coffee (often black), flavored sparkling water, or occasional “real” treats instead of daily sugar drinks.
GLP‑1 drugs and behavior change
- One camp is enthusiastic about GLP‑1 agonists as scalable tools that dampen food reward signals.
- Another warns this shifts dependence from food to pharma and should be a last resort after fixing diet and systems.
- Disagreement becomes sharp around whether “you can’t beat brain chemistry” vs. lifestyle change being sufficient for many.